RN7SKP122

Across TCGA pan-cancer cohorts, RN7SKP122 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RN7SKP122 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RN7SKP122 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP122 expression acts as an unfavorable survival marker.

UCEC, KIRC, and KICH are the cancer types where RN7SKP122 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.480	0.877	<.001	126	view →
KIRC	OS	Tertile	II,III,IV	0.127	0.806	<.001	84	view →
KICH	OS	Tertile	All	0.155	0.926	<.001	63	view →
STAD	DFS	Tertile	All	0.251	0.718	<.001	24	view →
PAAD	DFS	Tertile	All	0.100	0.505	.004	18	view →
OV	DFS	Tertile	III,IV	0.189	0.533	.019	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RN7SKP122–UCEC (OS)

Open the UCEC breakdown →